ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 123 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $10,255,000 | +35.1% | 107,356 | +0.2% | 0.01% | +18.2% |
| Q4 2018 | $7,588,000 | -58.6% | 107,124 | -50.0% | 0.01% | 0.0% |
| Q3 2018 | $18,310,000 | +414.6% | 214,248 | +597.9% | 0.01% | +175.0% |
| Q2 2018 | $3,558,000 | +53.4% | 30,698 | +7.1% | 0.00% | +33.3% |
| Q1 2018 | $2,320,000 | +37.9% | 28,668 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $1,682,000 | +29.1% | 28,668 | +3.0% | 0.00% | 0.0% |
| Q3 2017 | $1,303,000 | +30.0% | 27,843 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $1,002,000 | +29.1% | 27,843 | +10.6% | 0.00% | 0.0% |
| Q1 2017 | $776,000 | -5.4% | 25,182 | +2.9% | 0.00% | 0.0% |
| Q4 2016 | $820,000 | +30.0% | 24,482 | +3.3% | 0.00% | 0.0% |
| Q3 2016 | $631,000 | +20.7% | 23,705 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $523,000 | -25.0% | 23,705 | -0.2% | 0.00% | 0.0% |
| Q1 2016 | $697,000 | -11.1% | 23,743 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $784,000 | -8.6% | 23,743 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $858,000 | -17.7% | 23,743 | +2.4% | 0.00% | 0.0% |
| Q2 2015 | $1,043,000 | +133.9% | 23,193 | +59.1% | 0.00% | +100.0% |
| Q1 2015 | $446,000 | -38.0% | 14,578 | +3.1% | 0.00% | 0.0% |
| Q4 2014 | $719,000 | +28.4% | 14,140 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $560,000 | -8.0% | 14,140 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $609,000 | +160.3% | 14,140 | +141.5% | 0.00% | 0.0% |
| Q1 2014 | $234,000 | +87.2% | 5,856 | +28.3% | 0.00% | – |
| Q4 2013 | $125,000 | +19.0% | 4,566 | 0.0% | 0.00% | – |
| Q3 2013 | $105,000 | +29.6% | 4,566 | -0.6% | 0.00% | – |
| Q2 2013 | $81,000 | – | 4,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 564,102 | $42,184,000 | 14.63% |
| Fairmount Funds Management LLC | 387,400 | $28,970,000 | 9.55% |
| Soleus Capital Management, L.P. | 318,275 | $23,801,000 | 2.38% |
| Darwin Global Management, Ltd. | 166,190 | $12,428,000 | 1.90% |
| Paradigm Biocapital Advisors LP | 75,507 | $5,646,000 | 1.61% |
| ARMISTICE CAPITAL, LLC | 1,056,000 | $78,968,000 | 1.29% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 150,000 | $11,217,000 | 1.29% |
| Portland Global Advisors LLC | 75,869 | $5,673,000 | 0.95% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,573,829 | $117,691,000 | 0.59% |
| Yorktown Management & Research Co Inc | 10,400 | $778,000 | 0.52% |